KENNETH C FRAZIER

CIK 1181175 · Executive Chair · last filed 2026-03-04

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$115.97M

Companies

4

Total Filings

93

Lifetime Open-Market Net

-$453.27M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
EIKN Director 111,111 $8.75 $972.2K $2.00M 2 2026-03-04
MRK Executive Chair 915,989 $119.05 $109.05M -$455.27M 71 2022-11-08
XOM Director 40,500 $147.01 $5.95M $0 15 2022-05-26
Merck & Co., Inc. (MRKpB) Delisted President 149,836 $0 5 2010-08-03

Recent Filings · Page 3 of 10

93 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2019-05-07 MRK Grant (A) $0 EDGAR
2019-03-20 MRK Mixed -$8.24M EDGAR
2019-03-14 MRK Mixed -$799.7K EDGAR
2019-03-06 MRK Mixed -$858.8K EDGAR
2019-02-27 MRK Grant (A) +105,765 $8.50M EDGAR
2019-02-22 MRK Mixed -$3.91M EDGAR
2019-02-19 MRK Mixed -$5.52M EDGAR
2019-02-06 MRK Mixed -$8.98M EDGAR
2019-01-04 XOM Grant (A) +2,500 $0 EDGAR
2018-10-03 MRK Mixed -$9.94M EDGAR
Showing 2130 of 93
Page 3 of 10
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.